Biotech Values

[mcbio]

VRTX licenses a pair of pre-clinical nucleotides

I read no impact on VRUS into this news given that VRTX probably didn't want to cough up the amount of money that VRUS would have demanded and/or VRUS didn't want to partner with VRTX since VRUS can pretty much pick and choose who they want to partner with, if they want to partner at all.

However, I view this news as bearish for IDIX and INHX, since both have nukes that are further along than the ones VRTX licensed today.